KRAS and neoplasm: GSEA of premalignant livers from LP245/+ compared with LP+/+ revealed that tumor-promoting pathways such as KRAS signaling, MYC, and epithelial–mesenchymal transition (EMT) pathways were enriched in LP245/+ (Fig. 2B).